These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

405 related items for PubMed ID: 15022320

  • 1. MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor.
    Lin SK, Kok SH, Yeh FT, Kuo MY, Lin CC, Wang CC, Goldring SR, Hong CY.
    Arthritis Rheum; 2004 Mar; 50(3):785-93. PubMed ID: 15022320
    [Abstract] [Full Text] [Related]

  • 2. Oncostatin M-induced CCL2 transcription in osteoblastic cells is mediated by multiple levels of STAT-1 and STAT-3 signaling: an implication for the pathogenesis of arthritis.
    Kok SH, Hong CY, Kuo MY, Wang CC, Hou KL, Lin YT, Galson DL, Lin SK.
    Arthritis Rheum; 2009 May; 60(5):1451-62. PubMed ID: 19404962
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of osteoblast markers and induction of the glial fibrillary acidic protein by oncostatin M in osteosarcoma cells require PKCdelta and STAT3.
    Chipoy C, Berreur M, Couillaud S, Pradal G, Vallette F, Colombeix C, Rédini F, Heymann D, Blanchard F.
    J Bone Miner Res; 2004 Nov; 19(11):1850-61. PubMed ID: 15476586
    [Abstract] [Full Text] [Related]

  • 4. Transcriptional induction of cyclooxygenase-2 gene by okadaic acid inhibition of phosphatase activity in human chondrocytes: co-stimulation of AP-1 and CRE nuclear binding proteins.
    Miller C, Zhang M, He Y, Zhao J, Pelletier JP, Martel-Pelletier J, Di Battista JA.
    J Cell Biochem; 1998 Jun 15; 69(4):392-413. PubMed ID: 9620167
    [Abstract] [Full Text] [Related]

  • 5. Epigallocatechin-3-gallate diminishes CCL2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-Kinase/Akt/Raf-1 interaction: a potential therapeutic benefit for arthritis.
    Lin SK, Chang HH, Chen YJ, Wang CC, Galson DL, Hong CY, Kok SH.
    Arthritis Rheum; 2008 Oct 15; 58(10):3145-56. PubMed ID: 18821707
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of activator protein 1 activation, vascular endothelial growth factor, and cyclooxygenase-2 expression by 15-deoxy-Delta12,14-prostaglandin J2 in colon carcinoma cells: evidence for a redox-sensitive peroxisome proliferator-activated receptor-gamma-independent mechanism.
    Grau R, Iñiguez MA, Fresno M.
    Cancer Res; 2004 Aug 01; 64(15):5162-71. PubMed ID: 15289320
    [Abstract] [Full Text] [Related]

  • 7. Oncostatin M, an interleukin-6 family cytokine, upregulates matrix metalloproteinase-9 through the mitogen-activated protein kinase kinase-extracellular signal-regulated kinase pathway in cultured smooth muscle cells.
    Nagata T, Kai H, Shibata R, Koga M, Yoshimura A, Imaizumi T.
    Arterioscler Thromb Vasc Biol; 2003 Apr 01; 23(4):588-93. PubMed ID: 12615664
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-6 and oncostatin M-induced growth inhibition of human A375 melanoma cells is STAT-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/Kip1.
    Kortylewski M, Heinrich PC, Mackiewicz A, Schniertshauer U, Klingmüller U, Nakajima K, Hirano T, Horn F, Behrmann I.
    Oncogene; 1999 Jun 24; 18(25):3742-53. PubMed ID: 10391682
    [Abstract] [Full Text] [Related]

  • 9. Celecoxib inhibits phorbol ester-induced expression of COX-2 and activation of AP-1 and p38 MAP kinase in mouse skin.
    Chun KS, Kim SH, Song YS, Surh YJ.
    Carcinogenesis; 2004 May 24; 25(5):713-22. PubMed ID: 14729583
    [Abstract] [Full Text] [Related]

  • 10. Mitogen-activated protein kinases Erk1/2 and p38 are required for maximal regulation of TIMP-1 by oncostatin M in murine fibroblasts.
    Tong L, Smyth D, Kerr C, Catterall J, Richards CD.
    Cell Signal; 2004 Oct 24; 16(10):1123-32. PubMed ID: 15240007
    [Abstract] [Full Text] [Related]

  • 11. Induction of CCL13 expression in synovial fibroblasts highlights a significant role of oncostatin M in rheumatoid arthritis.
    Hintzen C, Quaiser S, Pap T, Heinrich PC, Hermanns HM.
    Arthritis Rheum; 2009 Jul 24; 60(7):1932-43. PubMed ID: 19565514
    [Abstract] [Full Text] [Related]

  • 12. Transcriptional activation of c-Fos by constitutively active Galpha(16)QL through a STAT1-dependent pathway.
    Lo RK, Wong YH.
    Cell Signal; 2006 Dec 24; 18(12):2143-53. PubMed ID: 16781847
    [Abstract] [Full Text] [Related]

  • 13. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response.
    Wang LH, Kirken RA, Erwin RA, Yu CR, Farrar WL.
    J Immunol; 1999 Apr 01; 162(7):3897-904. PubMed ID: 10201908
    [Abstract] [Full Text] [Related]

  • 14. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E, Sun S, Nan B, McPhaul MJ, Cheskis B, Mancini MA, Marcelli M.
    Cancer Res; 2004 Oct 01; 64(19):7156-68. PubMed ID: 15466214
    [Abstract] [Full Text] [Related]

  • 15. Oxidized LDL induces transcription factor activator protein-1 in rat mesangial cells.
    Wu ZL, Wang YC, Zhou Q, Ge YQ, Lan Y.
    Cell Biochem Funct; 2003 Sep 01; 21(3):249-56. PubMed ID: 12910478
    [Abstract] [Full Text] [Related]

  • 16. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT signaling pathway.
    Li WQ, Dehnade F, Zafarullah M.
    J Immunol; 2001 Mar 01; 166(5):3491-8. PubMed ID: 11207308
    [Abstract] [Full Text] [Related]

  • 17. Epidermal growth factor induces hypertrophic responses and Stat5 activation in rat ventricular cardiomyocytes.
    Rebsamen MC, Arrighi JF, Juge-Aubry CE, Vallotton MB, Lang U.
    J Mol Cell Cardiol; 2000 Apr 01; 32(4):599-610. PubMed ID: 10756117
    [Abstract] [Full Text] [Related]

  • 18. Involvement of tyrosine phosphatase PTP1D in the inhibition of interleukin-6-induced Stat3 signaling by alpha-thrombin.
    Gunaje JJ, Bhat GJ.
    Biochem Biophys Res Commun; 2001 Oct 19; 288(1):252-7. PubMed ID: 11594781
    [Abstract] [Full Text] [Related]

  • 19. Tumor necrosis factor-alpha up-regulates the expression of CCL2 and adhesion molecules of human proximal tubular epithelial cells through MAPK signaling pathways.
    Ho AW, Wong CK, Lam CW.
    Immunobiology; 2008 Oct 19; 213(7):533-44. PubMed ID: 18656701
    [Abstract] [Full Text] [Related]

  • 20. Oncostatin M-enhanced vascular endothelial growth factor expression in human vascular smooth muscle cells involves PI3K-, p38 MAPK-, Erk1/2- and STAT1/STAT3-dependent pathways and is attenuated by interferon-γ.
    Demyanets S, Kaun C, Rychli K, Pfaffenberger S, Kastl SP, Hohensinner PJ, Rega G, Katsaros KM, Afonyushkin T, Bochkov VN, Paireder M, Huk I, Maurer G, Huber K, Wojta J.
    Basic Res Cardiol; 2011 Mar 19; 106(2):217-31. PubMed ID: 21174212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.